METHOD OF CORRECTION OF IMMUNOLOGICAL STATUS OF PATIENTS WITH LUNG CANCER
medicine, oncology. SUBSTANCE: invention proposes to the of use relanium (diazepam) in the dose 5 mg, three times per a day for 7 days. Invention can be used for correction of immunological status of patients with lung cancer. EFFECT: enhanced effectiveness of lung cancer immunotherapy. 1 tbl
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | medicine, oncology. SUBSTANCE: invention proposes to the of use relanium (diazepam) in the dose 5 mg, three times per a day for 7 days. Invention can be used for correction of immunological status of patients with lung cancer. EFFECT: enhanced effectiveness of lung cancer immunotherapy. 1 tbl |
---|